Patent · US Active

Ether and alkyl phospholipid compounds for treating cancer and imaging and detection of cancer

US10004818B2 · kind B2 · utility

1Cited by
23References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 15, 2016
Grant dateJun 26, 2018
Priority date
Expiry dateApr 15, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N2005/1021
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods and compositions utilizing ether and alkyl phospholipid ether analog compounds for treating cancer and imaging, monitoring, and detecting cancer stem cells in humans.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.